Showing results (281-290 of 299) with videos related to

Sort By:
Pageof 30
Scientific Reports|December 11, 2023
Identifying primary aldosteronism patients who require adrenal venous sampling: a multi-center studyTakumi Kitamoto, Tsuyoshi Idé, Yuta Tezuka, et al.
Environmental Research|August 27, 2020
Prenatal exposure to perfluoroalkyl substances and behavioral difficulties in childhood at 7 and 11 yearsJiajun Luo, Jingyuan Xiao, Yu Gao, et al.
Journal of the American Heart Association|August 5, 2024
Primary Aldosteronism and Risk of Cardiovascular Outcomes: Genome-Wide Association and Mendelian Randomization StudyKosuke Inoue, Tatsuhiko Naito, Ryosuke Fuji, et al.
The Journal of Clinical Endocrinology and Metabolism|June 12, 2025
Clinical and Genetic Characteristics of Adult Nonautoimmune Hypothyroidism: A Single-Institution StudyChiho Sugisawa, Erika Uehara, Kanako Tanase-Nakao, et al.
Circulation|February 21, 2023
Genetic Risk of Primary Aldosteronism and Its Contribution to Hypertension: A Cross-Ancestry Meta-Analysis of Genome-Wide Association StudiesTatsuhiko Naito, Kosuke Inoue, Kyuto Sonehara, et al.
JAMA Cardiology|February 4, 2026
Cost-Effectiveness of Semaglutide for Secondary Prevention of Cardiovascular Disease in US AdultsSusan Hennessy, Joanne Penko, Brandon K Bellows, et al.
Journal of the American Heart Association|June 16, 2025
Prognostic Factors Associated With Early Recovery From Veno-Arterial Extracorporeal Membrane Oxygenation Support in Patients With Fulminant MyocarditisTomomi Ueda, Eisuke Amiya, Masaru Hatano, et al.
Endocrine Journal|April 7, 2022
Prediction model of Graves' disease in general clinical practice based on complete blood count and biochemistry profileAi Yoshihara, Jaeduk Yoshimura Noh, Kosuke Inoue, et al.
Thyroid : Official Journal of the American Thyroid Association|November 6, 2025
Survival Outcomes and Treatment Strategies in Primary Thyroid Lymphoma: A Population-Based Study of 401 Cases from the Tokyo Cancer RegistryYoshiyuki Saito, Natsuko Watanabe, Kosuke Inoue, et al.
BMJ Open|March 27, 2026
Platform trial of smartphone-based cognitive-behavioural therapy (CBT) for depressive symptoms among people with no or subthreshold depression: a protocol for the Best, Efficient and Affordable Training in Resilience in Constant Evolution (BEATRICE) platform trialToshi A Furukawa, Hisashi Noma, Masahiro Kojima, et al.
Pageof 30